Exhibit 10.2
FULCRUM THERAPEUTICS, INC.
EXECUTIVE EMPLOYMENT AGREEMENT
THIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is made as of May 12, 2023 (the “Effective Date”) by and between Fulcrum Therapeutics, Inc. (the “Company”) and Alex Sapir (the “Executive”) (the Company and the Executive each a “Party” and together the “Parties”).
RECITALS
WHEREAS, the Company desires to employ the Executive as its President and Chief Executive Officer; and
WHEREAS, the Executive has agreed to accept such employment on the terms and conditions set forth in this Agreement.
NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements of the Parties herein contained, the Parties hereto agree as follows:
Exhibit 10.2
Exhibit 10.2
Exhibit 10.2
Exhibit 10.2
Exhibit 10.2
provided, however, that in each case, the Company shall have a period of not less than thirty (30) days to cure any act constituting Good Reason following Executive’s delivery to the Company of written notice within sixty (60) days of the action or omission constituting Good Reason, and that the Executive actually terminates employment within thirty (30) days following the expiration of the Company’s cure period.
Exhibit 10.2
Exhibit 10.2
Exhibit 10.2
Exhibit 10.2
Exhibit 10.2
Exhibit 10.2
To Executive:
Alex Sapir
3829 Regent Road
Durham, NC 27707 To Company:
Fulcrum Therapeutics, Inc.
26 Landsdowne Street, 5th Floor Cambridge, MA 02139
Either Party may change the address to which notices are to be delivered by giving notice of such change to the other Party in the manner set forth in this Section 11.
Exhibit 10.2
Exhibit 10.2
IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the day and year set forth above.
FULCRUM THERAPEUTICS, INC.
| By: | /s/ Robert J. Gould |
|
|
|
| Name: | Robert J. Gould |
|
|
|
| Title: | Interim President and CEO |
|
|
|
EXECUTIVE:
By: | /s/ Alex S. Sapir |
|
|
Name: | Alex S. Sapir |